BamSEC and AlphaSense Join Forces
Learn More

Forte Biosciences Inc.

NASDAQ: FBRX    
Share price (1/6/25): $22.60    
Market cap (1/6/25): $33.0 million

Material Contracts Filter

EX-10.2
from 8-K 20 pages Form of Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 46 pages Securities Purchase Agreement by and Among Forte Biosciences, Inc., and the Purchasers November 19, 2024
12/34/56
EX-10.1
from 8-K 15 pages Forte Biosciences, Inc. Amended and Restated 2021 Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 12 pages 1. Voting Commitment. During the Restricted Period, at Each Annual or Special Meeting of Company’s Stockholders (Including Any Adjournments, Postponements or Other Delays Thereof) or Action by Written Consent of Company’s Stockholders, the Camac Fund Signatories Will Cause All Voting Securities (As Defined Below) That Are Beneficially Owned by the Camac Group to Be (A) Present for Quorum Purposes and (B) Voted or Consented (I) in Favor of the Election of Each Person Nominated by the Company’s Board of Directors (The “Board”) for Election as a Director; (II) Against Any Proposals or Resolutions to Remove Any Member of the Board; and (III) in Accordance With the Recommendation of the Board on All Other Proposals or Business That May Be the Subject of Stockholder Action at Such Meeting or Action by Written Consent. 2. Standstill. (A) Restricted Activities. During the Restricted Period, Each of the Camac Fund Signatories Agrees That It Will Not, and Shall Cause the Other Restricted Persons Not To, in Any Way, Directly or Indirectly (In Each Case, Except as Expressly Permitted by This Agreement)
12/34/56
EX-10.1
from 10-Q 14 pages Separation Agreement and Release
12/34/56
EX-10.17
from 10-K 3 pages Forte Biosciences, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.16
from 10-K 48 pages Forte Biosciences, Inc. 2021 Equity Incentive Plan 1. Purposes of the Plan. the Purposes of This Plan Are: • to Attract and Retain the Best Available Personnel for Positions of Substantial Responsibility, • to Provide Additional Incentive to Employees, Directors and Consultants, and • to Promote the Success of the Company’s Business. the Plan Permits the Grant of Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units and Performance Awards. 2. Definitions. as Used Herein, the Following Definitions Will Apply: 2.1 “Administrator” Means the Board or Any of Its Committees as Will Be Administering the Plan, in Accordance With Section 4 of the Plan. 2.2
12/34/56
EX-10.1
from 8-K 20 pages Forte Biosciences, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 19 pages Form of Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 45 pages Securities Purchase Agreement by and Among Forte Biosciences, Inc., and the Purchasers July 28, 2023
12/34/56
EX-10
from 10-K 14 pages Appendix a 2021 Equity Incentive Plan Forte Biosciences, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 11 pages Forte Biosciences, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.2
from 10-Q 3 pages Forte Biosciences, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 4 pages 3060 Pegasus Park Drive Building 6 Dallas, Texas 75247 May 31, 2022
12/34/56
EX-10.1
from 8-K 47 pages Forte Biosciences, Inc. Common Stock (Par Value $0.001 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.32
from 10-K 13 pages Appendix a 2021 Equity Incentive Plan Forte Biosciences, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 47 pages Forte Biosciences, Inc. Common Stock (Par Value $0.001 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.2
from S-8 11 pages Forte Biosciences, Inc. Stock Option Grant Notice
12/34/56
EX-10.1
from S-8 20 pages Forte Biosciences, Inc. 2020 Inducement Equity Incentive Plan
12/34/56
EX-10.7
from 10-Q 5 pages Certain Confidential Information Contained in This Document Has Been Omitted Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Information That Has Been Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. National Institutes of Health Second Amendment to L-018-2018/0
12/34/56